Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2000-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-8981(00)00336-3PMID 11020467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity.

  1999cited by this paper
• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

  1999cited by this paper
• Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.

  1999cited by this paper
• Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP.

  1999cited by this paper
• Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages.

  1998cited by this paper
• Plasma lipoproteins from patients with poorly controlled diabetes mellitus and “in vitro” glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins

  1997cited by this paper
• In vivo glucosylated LpA-I subfraction. Evidence for structural and functional alterations.

  1997cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Cholesterol efflux from macrophages and other cells

  1996cited by this paper
• Apolipoprotein-mediated removal of cellular cholesterol and phospholipids.

  1996cited by this paper
• Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls.

  1996cited by this paper
• Formation of new HDL particles from lipid-free apolipoprotein A-I.

  1996cited by this paper
• Regulation of Cellular Cholesterol Efflux by Lecithin:Cholesterol Acyltransferase Reaction through Nonspecific Lipid Exchange (*)

  1996cited by this paper
• Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages.

  1996cited by this paper
• Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.

  1996cited by this paper
• Cholesterol efflux from macrophages and other cells.

  1996cited by this paper
• Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

  1995cited by this paper
• Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*)

  1995cited by this paper
• Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL).

  1995cited by this paper
• Species difference in cholesteryl ester cycle and HDL-induced cholesterol efflux from macrophage foam cells.

  1994cited by this paper
• Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.

  1994cited by this paper
• Decreased ability of high density lipoproteins to transfer cholesterol esters in non‐insulin‐dependent diabetes mellitus

  1993cited by this paper
• Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus.

  1993cited by this paper
• Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells.

  1992cited by this paper
• Apolipoprotein A-I-Containing Particles and Reverse Cholesterol Transport in IDDM

  1992cited by this paper
• In vitro glycation of human apolipoprotein AI reduces its efficiency in lecithin:cholesterol acyltransferase activation.

  1991cited by this paper
• Accelerated cholesteryl ester transfer in patients with insulin‐dependent diabetes mellitus

  1991cited by this paper
• High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts.

  1991cited by this paper
• Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux

  1991cited by this paper
• Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol.

  1991cited by this paper
• Nonenzymatic Glycosylation of HDL Resulting in Inhibition of High-Affinity Binding to Cultured Human Fibroblasts

  1990cited by this paper
• Glycation of very low density lipoprotein from rat plasma impairs its catabolism

  1990cited by this paper
• Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.

  1990cited by this paper
• Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages

  1988cited by this paper
• In vivo conversion of human HDL3 to HDL2 and apoE-rich HDL1 in the rat: effects of lipid transfer protein.

  1987cited by this paper
• Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting.

  1987cited by this paper
• Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface.

  1987cited by this paper
• A receptor-mediated pathway for cholesterol homeostasis.

  1986cited by this paper
• Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

  1985cited by this paper
• Metabolism of high density lipoproteins reconstituted with [3H]cholesteryl ester and [14C]cholesterol in the rat, with special reference to the ovary.

  1985cited by this paper
• Nonenzymatic Glucosylation of High-Density Lipoprotein Accelerates Its Catabolism in Guinea pigs

  1982cited by this paper
• Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

  1982cited by this paper
• Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

  1976cited by this paper
• [38] The rapid determination of amino groups with TNBS.

  1972cited by this paper
• IN VIVO BEHAVIOR OF I131-FIBRINOGEN

  1963cited by this paper
• IN VIVO BEHAVIOR OF I-FIBRINOGEN.

  1963cited by this paper
• Phosphorus assay in column chromatography.

  1959cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Pleiotropic functions and clinical importance of circulating HDL-PON1 complex.

  2024cites this paper
• High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity

  2023cites this paper
• Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial

  2020cites this paper
• HDL and Reverse Cholesterol Transport.

  2019cites this paper
• Chapter 5 Type 1 Diabetes Mellitus Decreases in vivo Macrophage-to-Feces Reverse Cholesterol Transport Despite Increased Biliary Sterol Secretion in Mice

  2018cites this paper
• In vitro oxidized HDL and HDL from type 2 diabetes patients have reduced ability to efflux oxysterols from THP-1 macrophages.

  2018cites this paper
• Characterization of oxysterols produced in macrophages and mechanisms of regulation

  2016cites this paper
• Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study

  2016cites this paper
• Human FABP1 T94A variant enhances cholesterol uptake.

  2015cites this paper
• Lipoprotein Glycation in Diabetes Mellitus

  2014cites this paper
• Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease

  2014cites this paper
• Effect of GLP-1 based therapies on diabetic dyslipidemia.

  2014cites this paper
• Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages

  2013cites this paper
• Albumina modificada por glicação avançada sensibiliza macrófagos à inflamação prejudicando o transporte reverso de colesterol e a atividade anti-inflamatória da HDL

  2012cites this paper
• HDL functionality in diabetes mellitus: potential importance of glycation

  2012cites this paper
• Inibição do estresse oxidativo em macrófagos previne a redução no conteúdo do receptor ABCA-1 induzida por albumina modificada por glicação avançada

  2011cites this paper
• Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice

  2010cites this paper
• Reverse cholesterol transport in type 2 diabetes mellitus

  2009cites this paper
• Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux.

  2008cites this paper
• Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.

  2008cites this paper
• HDL atheroprotection by aerobic exercise training in type 2 diabetes mellitus.

  2008cites this paper
• Aerobic exercise training improves the role of high‐density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus

  2008cites this paper
• LECITHIN: CHOLESTEROL ACYLTRANSFERASE ACTIVITY IS DECREASED IN TYPE 2 DIABETES MELLITUS

  2007cites this paper
• The Roles of Protein Glycation, Glycoxidation, and Advanced Glycation End-Product Formation in Diabetes-Induced Atherosclerosis

  2006cites this paper
• Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.

  2006cites this paper
• Modified HDL: biological and physiopathological consequences.

  2006cites this paper
• Diminished macrophage cholesterol removal rate by the altered HDL metabolism in the Nagase analbuminemic rat

  2006cites this paper
• Cholesterol‐lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL study

  2005cites this paper
• Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment

  2005cites this paper
• High-density lipoprotein as a key component in the prevention of premature atherosclerotic disease in the insulin resistance syndrome.

  2004cites this paper
• High-Density Lipoprotein as a Key Component in the Prevention of Premature Atherosclerotic Disease in the Insulin Resistance Syndrome

  2004cites this paper
• Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.

  2004cites this paper
• Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins

  2003cites this paper
• Atherosclerosis: cell biology and lipoproteins Chondroitan sulphate proteoglycans and atherosclerosis Related review: Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherosclerosis

  2001cites this paper